Search

Search Constraints

You searched for: Author/Creator Gabra, Hani

Search Results

1. The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer. (15th June 2018)

2. Risk factors for endometrial cancer: An umbrella review of the literature. Issue 7 (20th February 2019)

3. Intravenous Versus Oral Dexamethasone Premedication in Preventing Paclitaxel Infusion Hypersensitivity Reactions in Gynecological Malignancies. Issue 7 (1st September 2013)

4. Risk of Ovarian Cancer Relapse Score: A Prognostic Algorithm to Predict Relapse Following Treatment for Advanced Ovarian Cancer. Issue 3 (1st March 2015)

5. 362 A PhII study of bemcentinib, a first-in-class selective AXL kinase inhibitor, in combination with pembrolizumab in pts with previously-treated advanced NSCLC: Updated clinical & translational analysis. (9th November 2020)

6. 362 A PhII study of bemcentinib, a first-in-class selective AXL kinase inhibitor, in combination with pembrolizumab in pts with previously-treated advanced NSCLC: Updated clinical & translational analysis. (9th November 2020)

10. P-OGC39 The smell of oesophageal adenocarcinoma: opportunities for tests and treatments. (16th December 2021)